The Pharmacy Times® Cardiovascular Health resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Statin use in certain patients may lead to increased muscle pain so severe it can affect adherence.
Janssen Submits sNDA to FDA for Expanded Use of Rivaroxaban in Patients with Peripheral Artery Disease
Janssen Pharmaceutical Companies submitted a supplemental New Drug Application (sNDA) to the FDA to expand the use of rivaroxaban in patients with peripheral artery disease.
Angiotensin receptor II blockers are often prescribed to control hypertension or for heart failure, kidney failure, or following a heart attack.
RG is a male patient aged 45 years who has arrived at the pharmacy to pick up his regular maintenance medications after recently losing 45 pounds in 3 months.
The objective for researchers in the new study was to determine whether the findings were generalizable in other populations by conducting a similar analysis in the United States, focusing on death from cardiovascular disease.
Lipid-lowering medication may be an effective adjuvant cancer therapy.
Dual Threats of COVID-19, Influenza Could Have Devastating Effects on Adults with Chronic Conditions
The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.
Cholesterol-lowering statins have been found to potentially reduce the risk of cancer via a pathway that is unrelated to its impact on cholesterol, according to a recent study.
Study shows that more than half of older patients hospitalized for heart failure are discharged with 10 or more prescriptions, putting them at significant risk for harm related to high medication burden.
After hospital admittance, the number of patients with heart failure who are on 10 or more medications rises.
CE: Implementing Effective Protocols When Using Direct Oral Anticoagulant Reversal Agents: A Review of Updated Guidelines and Clinical Data
This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.
Women found to have worse outcomes after a first heart attack than men.